German pharmaceutical company Bayer HealthCare has opened a new office in Yangon through its subsidiary Bayer Thai, the company announced.
Bayer also signed an agreement with India-based Mega Lifesciences – a distributor of pharmaceutical and consumer goods – to distribute products of Bayer’s healthcare division in Myanmar.
Bayer’s products to be distributed in Myanmar include contraceptives, medicines in therapeutic areas of infectious diseases, diabetes care, cardiovascular treatments, oncology and animal health.
“Myanmar is one of the fastest growing economies ASEAN. As the country continues to progress in its reforms, we look forward to help meet Myanmar’s healthcare goals, to increase access to innovative treatment options and accurate medical diagnostics in urban and rural areas,” said Celina Chew, country group head of Bayer North ASEAN Region.
Chew said Bayer aims to partner with healthcare professionals and the government to solve the tough challenges in healthcare development.
“Another area of priority for us is recruiting local talents to grow our healthcare business in Myanmar,” Chew added.
Dr Kyaw Zin Thant, director general of Medical Research (Lower Myanmar), Ministry of Health, said: “Myanmar wants to improve the public health and quality of life of its people as we face the daunting challenge of the increase in non-communicable diseases such as diabetes, hypertension, cardiovascular disorders and cancer.
“Bayer is a renowned innovator of medicines for high unmet medical needs and we welcome the company to our country.”
Myanmar will be a part of Bayer’s North ASEAN region, where the company has been operating for over 50 years.
The Bayer Group operates in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of €18.6 billion (2012), is one of the world’s leading companies in healthcare and medical products.
Bayer HealthCare has a global workforce of 54,900 employees as of 2012, and is represented in more than 100 countries.
